BridgeBio Pharma saw the highest growth of 2.59% in patent filings and 0.66% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.66% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of BridgeBio Pharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
BridgeBio Pharma has been focused on protecting inventions in Australia(AU) with seven publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 33% of filings. The Australia(AU), Israel(IL), Argentina(AR), and European Patent Office(EPO) patent Office are among the top ten patent offices where BridgeBio Pharma is filings its patents. Among the top granted patent authorities, BridgeBio Pharma has 33% of its grants in United States(US), 17% in European Patent Office(EPO) and 17% in Israel(IL).
Roche and Johnson & Johnson could be the strongest competitors for BridgeBio Pharma
Patents related to rare diseases and cell & gene therapy lead BridgeBio Pharma's portfolio
BridgeBio Pharma has the highest number of patents in rare diseases followed by, cell & gene therapy and genomics. For rare diseases, nearly 80% of patents were filed and 100% of patents were granted in Q2 2024.
Melanoma related patents lead BridgeBio Pharma portfolio followed by solid tumor, and non-small cell lung cancer
BridgeBio Pharma has highest number of patents in melanoma followed by solid tumor, non-small cell lung cancer, small-cell lung cancer, and gastric cancer. For melanoma, nearly 7% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of BridgeBio Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
